(Q47873853)

English

Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder.

scientific article published on 26 March 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder. (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

3

object named as

Birgit Högl

1 reference

Europe PubMed Central

6 February 2018

14

object named as

Werner Poewe

1 reference

Europe PubMed Central

6 February 2018

8

object named as

Eduardo Tolosa

1 reference

Europe PubMed Central

6 February 2018

2

object named as

Klaus Seppi

1 reference

Europe PubMed Central

6 February 2018

10

object named as

Elke Gizewski

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

Michael Schocke

11

object named as

Michael Schocke

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

Christoph Scherfler

5

object named as

Christoph Scherfler

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

Roberto De Marzi

1

object named as

Roberto De Marzi

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

author name string

Christoph Müller

4

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

Ambra Stefani

6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

Alex Iranzo

7

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

Joan Santamarìa

9

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

Elisabeth Skalla

12

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

Christian Kremser

13

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

publication date

26 March 2016

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

Annals of Neurology

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

79

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

1026-1030

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients

1 reference

https://api.crossref.org/works/10.1002%2FANA.24646

21 January 2018

Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials

1 reference

https://api.crossref.org/works/10.1002%2FANA.24646

21 January 2018

Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FANA.24646

21 January 2018

Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series.

1 reference

https://api.crossref.org/works/10.1002%2FANA.24646

21 January 2018

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

1 reference

https://api.crossref.org/works/10.1002%2FANA.24646

21 January 2018

Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD.

1 reference

https://api.crossref.org/works/10.1002%2FANA.24646

21 January 2018

Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.

1 reference

https://api.crossref.org/works/10.1002%2FANA.24646

21 January 2018

Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.

1 reference

https://api.crossref.org/works/10.1002%2FANA.24646

21 January 2018

The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T

1 reference

https://api.crossref.org/works/10.1002%2FANA.24646

21 January 2018

Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality

1 reference

https://api.crossref.org/works/10.1002%2FANA.24646

21 January 2018

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1002%2FANA.24646

21 January 2018

Identifiers

10.1002/ANA.24646

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/27016314

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47873853&oldid=1859586852"